Skip to main content
Premium Trial:

Request an Annual Quote

Brian Osborne, Severin Schwan, Franz Humer, Dan Stoicescu

Premium
Brian Osborne has joined BioTeam as a principal investigator, the Boston-based company said last week. He will help clients with “challenges in high performance computing, informatics, and next-generation sequencing,” according to the company. Osborne comes to BioTeam from his own consulting company, ZBIO. Prior to that, he was both CTO and director of informatics at Cognia, and director of IT at OSI Pharmaceuticals. Previously, he was also group leader for bioinformatics at Cadus Pharmaceuticals and worked in the plant genome sequencing lab at the University of California, Berkeley. Osborne holds a PhD in biology from the Massachusetts Institute of Technology and a bachelor’s degree from Hampshire College.
 

 
Severin Schwan took over as CEO of Roche at the company’s annual general meeting this week. He succeeds Franz Humer. Schwan, who was previously CEO of Roche Diagnostics, a division of Roche, had been scheduled to become Roche’s CEO since last fall.
 

 
Dan Stoicescu has become the second customer of Cambridge, Mass.-based personal genome sequencing startup Knome, according to an article in the New York Times this week. He is the founder of Sindan, a company based in Bucharest, Romania, holds a PhD in medicinal chemistry, and lives in Switzerland, according to the article.